In a time when everything is changing all at once—on/off tariffs, federal funding and agencies disappearing with the stroke ...
Responsible Leadership isn’t just about running a business; it’s about shaping its role in society. It’s leadership anchored ...
The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous (SC) formulation for the treatment of adult ...
The Cool Down on MSNOpinion
PhD student debunks common misconception about electric vehicles: 'It is 100% wrong'
"Basically propaganda from the ... industry." PhD student debunks common misconception about electric vehicles: 'It is 100% ...
How One Invasive Vine Can Choke Out Your Entire Garden In Weeks. Image Source: ShutterstockGardens are supposed to be ...
Lunsumio VELO reduces administration time from 2-4 hours to approximately one minuteAvailability of Lunsumio VELO allows treatment aligned to people’s clinical needs and personal preferences Approval ...
Placental demands for energy were not included in the current Recommended Daily Allowance for carbohydrate in pregnant ...
Many multi-unit residential buildings are designed or managed in ways that make recycling and proper waste disposal difficult ...
Vermont has one of the highest rates of pediatric asthma in the country — one analysis found that in Vermont, 8.3% of people under the age of 17 have asthma, according to 2023-24 data from the U.S.
In 2025, cardiology delved deeper into sex-specific risk factors and how to leverage them in prevention, Stacey Rosen says.
Lunsumio VELO, a CD20xCD3 bispecific antibody, is approved for relapsed or refractory follicular lymphoma after two or more systemic therapies. The GO29781 trial showed a 75% objective response rate ...
Parul University held its ninth convocation ceremony today, Monday, December 22, where more than 16,000 students from the class of 2025 graduated. The ceremony ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results